Comparison of COVID-19 and seasonal influenza under different intensities of non-pharmaceutical interventions and vaccine effectiveness

Yinchang Chen, Zhende Wang, Feng Li, Jingyu Ma, Jie Zhang, Yunpeng Chen, Ting ZhangFrontiers in Public Health 2022 · DOI

Abstract

The effectiveness of the COVID-19 CoronaVac vaccine for preventing severe outcomes is superior to its ability to prevent infection. For the long-term prevention and control of influenza, this study recommends prioritizing vaccination over strict non-pharmaceutical interventions (NPIs).

Introduction: The Strategic Dilemma of Co-existence

As the global community transitions from emergency pandemic response to a "co-existence" model with respiratory viruses, public health officials face a strategic dilemma: how to balance social restrictions (NPIs) with vaccination efforts. While NPIs like social distancing and travel limits successfully suppressed both COVID-19 and influenza, they carry heavy economic and psychological costs.

This paper quantifies the relative impact of these interventions on two different pathogens. By modeling various scenarios, the authors aim to provide a scientific basis for "dynamic zero-COVID" policies versus more relaxed strategies, specifically comparing how the timing and scale of infection peaks differ between COVID-19 and seasonal influenza.

Methodology: The Improved SEIR Model

The researchers developed an improved SEIR (Susceptible-Exposed-Infectious-Removed) model that further categorizes the "Infectious" group into three distinct compartments based on clinical severity.

The improved SEIR model transmission chain, showing the flow from Susceptible to Removed through varying levels of clinical severity.

The model includes six compartments:

  • Susceptible (S)
  • Exposed (E)
  • Mild cases ($I_1$): Asymptomatic or mild symptoms.
  • Moderate cases ($I_2$): Pneumonia visible on imaging.
  • Severe cases ($I_3$): Respiratory failure or ICU admission.
  • Removed (R)

The model simulated a hypothetical city of 100,000 people across 10 scenarios. These scenarios varied the intensity of NPIs (Level 1 to Level 3) and vaccination status. NPI levels ranged from basic work-from-home advisories (Level 1) to the closure of all schools and strict restaurant bans (Level 3).

Data and Parameters

The study populates its mathematical model using epidemiological parameters derived from established literature:

  • COVID-19 (Omicron): Vaccine effectiveness (VE) for three doses of CoronaVac was set at 33% against infection, based on real-world data from Hong Kong and Malaysia.
  • Influenza: Based on historical seasonal flu data, with VE set at 50% against infection.
  • NPI Effectiveness: Quantified based on how different levels of social restriction reduce the effective reproduction number ($R_t$).

Key Insights: Severity vs. Infection

A critical finding is that the CoronaVac vaccine is significantly better at preventing severe outcomes (26.57% reduction in peak severe cases) than it is at preventing infection (10.16% reduction). This reinforces the shift in public health focus from "stopping spread" to "preventing hospitalization."

Furthermore, COVID-19 (Omicron) moves much faster than influenza. In a natural state, COVID-19 peaked around day 23, while influenza peaked around day 50. This shorter window for COVID-19 creates a much higher risk of overwhelming healthcare infrastructure.

Influenza is remarkably sensitive to NPIs. Under Level 3 restrictions, the scale of a flu outbreak becomes almost negligible. However, because flu vaccines are highly effective (reducing severe cases by nearly 90% in the model), vaccination should be the priority over the "blunt instrument" of strict NPIs for long-term management.

Results Summary

  • COVID-19 Impact: Three doses of vaccine reduced the peak number of severe cases by 26.57% and delayed the peak of infections by 6 days. Moving from Level 1 to Level 3 NPIs reduced peak severe cases by 15.43% and peak infections by 28.28%.
  • Influenza Impact: Vaccination of the entire population reduced the peak number of severe cases by 89.85% and infections by 79.89%.
  • Natural Peak Scale: In the "natural" scenario, COVID-19 infections peaked at 51,294 cases, while influenza peaked at 21,827 cases. Severe cases for COVID-19 were roughly 6.32 times higher than for influenza.

Limitations and Future Directions

The authors acknowledge several limitations: the model treats NPIs as broad levels rather than specific actions, assumes constant vaccine effectiveness without accounting for waning immunity, and uses a homogeneous population model. Future research should integrate waning immunity curves and economic cost-benefit analyses to determine the exact point where NPIs become more costly than the disease burden they prevent.

Summary updated

Abstract

The effectiveness of COVID-19 coronaVac vaccine for preventing severe outcomes is better than preventing infection; for the prevention and control of influenza, we recommend influenza vaccination as a priority over strict NPIs in the long term.
BibTeX
@inproceedings{chen2022comparison,
  author = {Yinchang Chen and Zhende Wang and Feng Li and Jingyu Ma and Jie Zhang and Yunpeng Chen and Ting Zhang},
  title = {{Comparison of COVID-19 and seasonal influenza under different intensities of non-pharmaceutical interventions and vaccine effectiveness}},
  booktitle = {Frontiers in Public Health},
  year = {2022},
  doi = {10.3389/fpubh.2022.973088},
}
Figure